类风湿关节炎的表观遗传学:非编码RNA的贡献
本文综述了microRNA与长链非编码RNA在类风湿关节炎发病机制中的作用及其治疗潜力。研究汇总了人类RA组织、细胞系及动物模型中非编码RNA表达变化的证据,探讨了其作为标志物及靶向抑制炎症的可能性。目前相关药物技术尚处早期,尚无进入临床试验者,但部分方向前景可期。
要点
- 非编码RNA参与类风湿关节炎多个发病环节,在患者组织、细胞系及动物模型中表达改变。
- 部分非编码RNA被提出可作为类风湿关节炎的候选标志物。
- 靶向microRNA或lncRNA通路以抑制炎症的药物技术尚处早期,未进入临床试验。
核心结论
- 非编码RNA(包括microRNA和长链非编码RNA)参与类风湿关节炎的发病过程,并具有作为标志物和治疗靶点的潜在价值。
- 尽管相关研究仍处于非常早期的阶段,但已有大量研究证实非编码RNA在类风湿关节炎发展中的作用。
研究设计与样本
- 本文为综述,汇总了关于microRNA和长链非编码RNA在类风湿关节炎发病机制中贡献及潜在治疗应用的最新研究结果。
主要发现
- 研究显示非编码RNA在人类类风湿关节炎的各种组织或细胞系以及类风湿关节炎动物模型中存在表达变化。
- 文中尝试阐述了导致非编码RNA表达改变的可能机制。
- 有研究提出将部分非编码RNA用作类风湿关节炎标志物的设想。
- 已有非常先进的药物制备技术被提出,旨在通过影响microRNA或lncRNA通路来抑制类风湿关节炎患者的炎症。
临床怎么用
- 目前非编码RNA作为类风湿关节炎标志物或治疗靶点尚处于研究阶段,未进入临床试验,暂不能用于临床常规诊疗。
- 临床医生可关注非编码RNA作为潜在标志物和治疗靶点的研究进展,但目前不应据此改变临床决策。
局限性
- 当前关于非编码RNA在类风湿关节炎中应用的研究阶段仍非常早期。
- 文中提及的靶向microRNA或lncRNA通路的药物技术均未进入临床试验阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since microRNA was discovered in the late 1990s the role of non-coding RNAs in the regulation of cellular processes has been confirmed. Intensive researches have revealed a number of subtypes of non-coding RNA. It has been proved that these molecules can influence each step of the development of cells and tissues. Moreover, researchers have found their expression change during disease development. In this article, we gathered the current results on the contribution of microRNA and long non-coding RNA in rheumatoid arthritis pathogenesis and their potential use in rheumatoid arthritis treatment. Although the present stage of studies on this matter is still very early, many studies have confirmed non-coding RNAs' involvement in rheumatoid arthritis development. We showed ncRNAs changes in various tissues or cell lines of RA in humans or in animal models of RA. We tried to present possible mechanisms causing respective modifications of ncRNAs expression. There are some propositions to use some of them as markers of rheumatoid arthritis. Moreover, very advanced techniques of drug preparation are proposed to influence the microRNA or lncRNA pathways to inhibit inflammation in RA patients. None of them are now at the trial stage, but some are very promising.
引用
- Kolarz B, Majdan M. Epigenetic aspects of rheumatoid arthritis: contribution of non-coding RNAs. Semin Arthritis Rheum. 2017. PMID: 28285723. doi:10.1016/j.semarthrit.2017.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。